Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
December 20, 2021
Doyle v. REATA PHARMACEUTICALS, INC. et al
Case Number:
4:21-cv-00987
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Burns Charest
- Davis Polk
- Federman & Sherwood
- Shearman & Sterling
- Siebman Law
- Steckler Wayne
- Vinson & Elkins
Companies
- Barclays PLC
- Cantor Fitzgerald
- Cantor Fitzgerald LP
- Citigroup Inc.
- Jefferies Financial Group Inc.
- Ladenburg Thalmann Financial Services Inc
- Reata Pharmaceuticals Inc.
- Robert W. Baird & Co. Inc.
- SVB Securities
- The Goldman Sachs Group Inc.
- Wespath Institutional Investments LLC
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
November 03, 2023
Reata Inks $45M Deal With Investors Over Failed Drug
Reata has inked a $45 million settlement to resolve claims it misled investors by not disclosing the U.S. Food and Drug Administration's misgivings about the company's trial of a kidney drug, according to a motion for settlement approval filed Friday in Texas federal court.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login